Kavar Capital Partners Group, LLC Merck & Co., Inc. Transaction History

Kavar Capital Partners Group, LLC

  • $733 Million
  • Q3 2025

A detailed history of Kavar Capital Partners Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kavar Capital Partners Group, LLC holds 16,328 shares of MRK stock, worth $1.52 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
16,328
Previous 16,431 0.63%
Holding current value
$1.52 Million
Previous $1.3 Million 5.38%
% of portfolio
0.19%
Previous 0.19%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025
SELL
$77.6 - $87.37 $7,992 - $8,999
-103 Reduced 0.63%
16,328 $1.37 Million
Q2 2025

Jul 17, 2025
SELL
$73.47 - $87.12 $7,273 - $8,624
-99 Reduced 0.6%
16,431 $1.3 Million
Q1 2025

Apr 23, 2025
SELL
$83.01 - $101.02 $10,957 - $13,334
-132 Reduced 0.79%
16,530 $1.48 Million
Q4 2024

Jan 22, 2025
SELL
$96.31 - $114.76 $47,095 - $56,117
-489 Reduced 2.85%
16,662 $1.66 Million
Q3 2024

Oct 24, 2024
SELL
$111.15 - $128.97 $16,450 - $19,087
-148 Reduced 0.86%
17,151 $1.95 Million
Q2 2024

Jul 19, 2024
SELL
$123.8 - $132.96 $4,952 - $5,318
-40 Reduced 0.23%
17,299 $2.14 Million
Q1 2024

May 14, 2024
SELL
$113.24 - $131.95 $1.08 Million - $1.26 Million
-9,523 Reduced 35.45%
17,339 $2.29 Million
Q4 2023

Feb 14, 2024
BUY
$100.18 - $109.02 $1.22 Million - $1.33 Million
12,173 Added 82.87%
26,862 $2.93 Million
Q3 2023

Nov 06, 2023
SELL
$102.95 - $114.33 $36,444 - $40,472
-354 Reduced 2.35%
14,689 $1.51 Million
Q2 2023

Aug 07, 2023
SELL
$108.61 - $118.38 $434 - $473
-4 Reduced 0.03%
15,043 $1.74 Million
Q1 2023

May 12, 2023
SELL
$102.94 - $114.86 $15,132 - $16,884
-147 Reduced 0.97%
15,047 $1.6 Million
Q4 2022

Feb 10, 2023
SELL
$87.44 - $112.11 $77,646 - $99,553
-888 Reduced 5.52%
15,194 $1.69 Million
Q3 2022

Nov 08, 2022
SELL
$84.53 - $94.96 $96,955 - $108,919
-1,147 Reduced 6.66%
16,082 $1.39 Million
Q2 2022

Aug 09, 2022
BUY
$83.49 - $94.64 $10,686 - $12,113
128 Added 0.75%
17,229 $1.57 Million
Q1 2022

May 09, 2022
BUY
$73.51 - $82.4 $1,837 - $2,060
25 Added 0.15%
17,101 $1.4 Million
Q4 2021

Jan 27, 2022
SELL
$72.28 - $90.54 $40,838 - $51,155
-565 Reduced 3.2%
17,076 $1.31 Million
Q3 2021

Nov 01, 2021
BUY
$71.68 - $78.83 $19,712 - $21,678
275 Added 1.58%
17,641 $1.33 Million
Q2 2021

Aug 02, 2021
SELL
$70.31 - $77.77 $31,639 - $34,996
-450 Reduced 2.53%
17,366 $1.35 Million
Q1 2021

May 13, 2021
BUY
$68.86 - $81.11 $234,124 - $275,774
3,400 Added 23.58%
17,816 $1.37 Million
Q4 2020

Feb 05, 2021
BUY
$71.77 - $79.65 $1.03 Million - $1.15 Million
14,416 New
14,416 $1.18 Million

Others Institutions Holding MRK

# of Institutions
3,878
Shares Held
1.9B
Call Options Held
30.1M
Put Options Held
27.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $235B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Kavar Capital Partners Group, LLC Portfolio

Follow Kavar Capital Partners Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kavar Capital Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kavar Capital Partners Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email